Funded by a $22 million grant from the National Institutes of Health and Three Lakes Partners, the PRECISIONS study aims to transform diagnosis and treatment for idiopathic pulmonary fibrosis.
The 7th Annual RRR (Results, Rewards, Recognition) Reception was held at the Griffis Faculty Club on November 7, 2019.
Results of a recent study that used a new drug combination (glecaprevir/pibrentasivr) for chronic HCV and compensated cirrhosis of the liver, showed high virological cure rates.
A tribute to Dr. King’s legacy was held on October 2, 2019 at the Griffis Faculty Club as part of the division’s Briscoe-King Lung Club.
Dr. Aram Kim and Dr. Michael Torres-Lizardi have been appointed Associate Clerkship Directors for the Internal Medicine Clerkship.
The grant seeks to understand the opportunities and challenges posed by cognitive restoration for people with severe to moderate traumatic brain injury in the context of the Americans with Disabilities Act.
The Diversity Center of Excellence has launched programs and initiatives fostering excellence and support for underrepresented minorities. A new video highlights leaders in diversity and future strategies.
The award will fund Dr. Guo's research into how hundreds of different bacterial species living in the human gut contribute to human health and disease.
Dr. Suthanthiran's talk was entitled “Monitoring the Allograft in the 21st Century: From the Microscope to Molecular Scan.”
Dr. Melnick and his team have developed an SIRT3-blocking compound that rapidly kills diffuse large B cell lymphoma cells in the culture dish and in mice.
